Table 3.

Comparison of TAP-ANV and a combination of TAP and ANV in TF-initiated plasma clotting, aPTT, and a mouse thrombosis model




TF-initiated clotting time,*s

aPTT,s

Occlusion time,min
Control   42.3 ± 1.3 (n = 7)   33.2 ± 1.0 (n = 4)   57 ± 10.2 (n = 5)  
TAP-ANV   60.7 ± 1.2 (n = 7)§  52.8 ± 2.1 (n = 4)§  80 ± 13.5 (n = 6)§ 
TAP + ANV
 
42.5 ± 0.6 (n = 7)
 
36.9 ± 0.9 (n = 4)§
 
49 ± 2.4 (n = 5)
 



TF-initiated clotting time,*s

aPTT,s

Occlusion time,min
Control   42.3 ± 1.3 (n = 7)   33.2 ± 1.0 (n = 4)   57 ± 10.2 (n = 5)  
TAP-ANV   60.7 ± 1.2 (n = 7)§  52.8 ± 2.1 (n = 4)§  80 ± 13.5 (n = 6)§ 
TAP + ANV
 
42.5 ± 0.6 (n = 7)
 
36.9 ± 0.9 (n = 4)§
 
49 ± 2.4 (n = 5)
 

Values are mean ± SD.

*

Plasma was supplemented with buffer (control), 2.5 nM fusion protein (TAP-ANV), or 2.5 nM TAP and 2.5 nM ANV (TAP + ANV), and the TF-initiated clotting was determined using a fibrometer

Plasma was supplemented with buffer (control), 50 nM fusion protein (TAP-ANV), or 50 nM TAP and 50 nM ANV (TAP + ANV), and the aPTT was determined using a fibrometer

Mice were injected with PBS (control), 0.23 nmol/kg (10 μg/kg) fusion protein (TAP-ANV), or a mixture of 0.23 nmol/kg TAP and 0.23 nmol/kg ANV (TAP + ANV), and the occlusion time was determined as described in “Materials and methods”

§

P ≤ .01 versus control (2-tailed t test)

Close Modal

or Create an Account

Close Modal
Close Modal